What's Going On With Novavax Hitting A New 52-Week Low?

Zinger Key Points
  • Novavax shares are trading lower by 3.5% during Wednesday's session.
  • Shares of several COVID vaccine stocks are trading lower after Pfizer provided FY24 guidance.

Novavax Inc NVAX shares are trading lower by 4.4% to $5.08 Wednesday afternoon. Shares of several COVID vaccine stocks are trading lower after Pfizer Inc. provided FY24 guidance.

Pfizer's guidance might hint at a saturation point in the COVID vaccine market. If projections indicate slower growth or lower revenue due to factors like vaccine hesitancy, reaching market saturation or declining demand, investors might worry about similar challenges for other vaccine manufacturers.

What Happened With Pfizer?

Pfizer revealed its projected earnings for 2024, factoring in the Seagen Inc acquisition, which was approved by regulators roughly nine months after its announcement.

The anticipated revenue for FY24 is estimated at $58.5 billion to $61.5 billion due to the addition of Seagen. However, this falls below the consensus estimate of $63.17 billion....Read More

According to data from Benzinga Pro, NVAX has a 52-week high of $18.22 and a 52-week low of $5.06.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsSmall Capwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!